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Abstract
Influenza viruses possess at their surface two glycoproteins, the hemagglutinin and the neuraminidase, of which the
antagonistic functions have to be well balanced for the virus to grow efficiently. Ferraris et al. isolated in 2003–2004 viruses
lacking both a NA gene and protein (H3NA- viruses) (Ferraris O., 2006, Vaccine, 24(44–46):6656-9). In this study we showed
that the hemagglutinins of two of the H3NA- viruses have reduced affinity for SAa2.6Gal receptors, between 49 and 128
times lower than that of the A/Moscow/10/99 (H3N2) virus and no detectable affinity for SAa2.3Gal receptors. We also
showed that the low hemagglutinin affinity of the H3NA- viruses compensates for the lack of NA activity and allows the
restoration of the growth of an A/Moscow/10/99 virus deficient in neuraminidase. These observations increase our
understanding of H3NA- viruses in relation to the balance between the functional activities of the neuraminidase and
hemagglutinin.
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Introduction
Each winter, influenza epidemics have a considerable impact on
the population in terms of morbidity and mortality. Influenza A
viruses present at their surface two glycoproteins, the hemagglu-
tinin (HA) and the neuraminidase (NA). The HA allows the virus
to bind to the host cell through its binding to cellular sialylated
glycoconjugates and recognizes two principal types of sialic acid
receptors : sialic acids bound to galactose by a a2.3 link
(SAa2.3Gal) or by a a2.6 link (SAa2.6Gal). The NA, through its
sialidase activity, releases progeny virions from host cells and has
both a2.3 and a2.6 receptor cleavage capacity.
The two proteins, HA and NA, have apparent antagonistic
functions : the HA is a receptor binding protein and the NA a
receptor destroying enzyme. However, these roles are comple-
mentary and their activities must be well balanced for the virus
to exhibit good fitness. The counterbalancing of defects in the
NA by decrease in HA receptor binding affinity is a well known
mechanism observed in drug resistant NA mutants [1,2,3], in
mutants lacking the coding capacity for the NA gene [4,5,6] or
in stalkless NA mutants [7,8]. Equilibration of the balance
between the HA and NA has been shown to be necessary for
the virus to adapt to a new host [9,10] or after genetic
reassortment [11,12] [13].
Ferraris et al. reported the isolation in 2003–2004 of four
neuraminidase inhibitor-resistant mutants lacking the entire NA
gene and protein (H3NA- viruses) [14]. Further studies indicated
the essential role of the HAs of two H3NA- viruses (A/Lyon-
CHU/26430/03, Genbank JF421757 and A/Reunion/586/04,
Genbank JF421758) in compensating for the absence of NA [15].
In the present study, we observed that the HA of the H3NA-
viruses has low affinity for SAa2.6Gal receptors and no detectable
affinity for SAa2.3Gal receptors, rendering the virus less
dependent on NA activity.
In a previous study, we identified a recombinant A/Moscow/
10/99 (H3N2) virus deficient in NA activity which contains two
structural mutations in the NA active site (E119D/I222L) [16].
This combination of two mutations has however not been
observed in the clinic. The E119D mutation has been observed
in vitro in N2 subtype viruses following passage under zanamivir
selection [1,17]. The I222L mutation has been observed in H5N1
viruses isolated from birds conferring a reduced sensitivity to
oseltamivir [18]. The virus possessing the double mutation in NA
was able to grow in MDCK cells only in the presence of
complementary bacterial NA activity, suggesting that the activity
of the NA was abolished by the double mutation E119D/I222L.
In this paper, we confirmed that the E119D/I222L mutation in
NA has a detrimental effect on the NA activity and showed that
the low sialic acid receptor affinity of the HA of the H3NA- viruses
was able to counterbalance the deficiency in NA activity caused by
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e33880the combination of the two E119D and I222L mutations, but not
the absence of a NA gene.
Results
Differences in HA Affinity for Sialic Acid Receptors
We hypothesized that the affinities of the HAs of the A/Lyon-
CHU/26430/03 and A/Reunion/586/04 H3NA- viruses may be
low, to counterbalance the absence of NA activity. To verify this,
we first measured the dissociation constant Kd of the A/Lyon-
CHU/26430/03 and A/Reunion/586/04 natural isolates using
biotinylated sialylglycopolymers (39SL and 69SLN) (Figure 1).
To analyse the results, the blank-corrected data were fitted with
two non-linear regression models. The first model (MM model)
corresponds to a classic Michaelis-Menten model and assumes that
there is one site per receptor (i.e. monomer). The second model
(MM2 model) is an adaptation of the Michaelis-Menten model
with the assumption that there are two sites of different affinities
per receptor. This model relates to the presence of a secondary
sialic acid site in the HA, detected in crystallographic studies [19].
We use the Bayesian Information Criterion (BIC) to objectively
discriminate between these two models.
We observed that the MM2 model was better for interpreting
the results from binding assays with 69SLN and 39SL receptors for
the A/Moscow/10/99 virus, implying that we may detect a signal
resulting from the binding of sialylated receptors to the secondary
site. For the A/Moscow/10/99 virus, the Kd constant given by the
MM model and the Kd1 constant by the MM2 model,
representing the affinity of the primary sialic acid site in HA, i.e.
receptor binding site (RBS), for sialylated receptors, are in the
same range for both 69SLN and 39SL receptors, showing model
coherence. The Kd2 constants detected in the MM2, representing
affinity of the secondary sialic acid site in HA for sialylated
receptors, is 20 and 13 times lower than the Kd1 constants for
69SLN and 39SL, respectively. A better fit with the MM regression
was obtained for the results of binding assays of the H3NA- viruses
with 69SLN receptors. This suggests that in those conditions, the
secondary sialic acid site was not detected, maybe in relation to the
Figure 1. Affinities of the HAs of the H3NA- viruses for sialylglycopolymers. Binding curves were fitted with the two models MM and MM2
for A/Moscow/10/99, A/Lyon-CHU/26430/03 and A/Reunion/586/04 viruses with 69SLN receptors (A) and 39SL receptors (B). The values of the
dissociation constant (Kd) of the three viruses for 69SLN receptors (C) and 39SL receptors (D) calculated from the two models (MM and MM2) are
indicated. The values correspond to the mean +/– standard deviation calculated from three independent assays. The Bayesian Information Criterion
(BIC) is indicated for each regression.
doi:10.1371/journal.pone.0033880.g001
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MM2 regression could be obtain as a result of the low signal.
In fine, the A/Lyon-CHU/26430/03 and A/Reunion/586/04
H3NA- viruses possessed affinities for 69SLN receptors respec-
tively 49 and 128 times lower than the A/Moscow/10/99 virus.
The affinities of the A/Lyon-CHU/26430/03 and A/Reunion/
586/04 viruses for 39SL receptors were hardly detectable and
could not be interpreted even with the MM model, as binding
could not be distinguished from the non-specific signal. The
affinity of the A/Moscow/10/99 HA for 39SL receptors is 20
times lower than for 69SLN receptors.
Generation of Recombinant Viruses Containing HA with
Low Affinity
To test our hypothesis that a virus containing a deficient NA
would be rescued when combined with an HA of decreased
affinity for sialic acid receptors, we produced, by reverse genetics,
recombinant viruses containing the deficient E119D/I222L NA
and the HA of the A/Lyon-CHU/26430/03 (L/E119D/I222L)
or A/Reunion/586/04 (R/E119D/I222L) H3NA- strains on the
A/Moscow/10/99 genetic background. In parallel, construction
of viruses containing the HAs of A/Lyon-CHU/26430/03 (L/
H3NA-) and A/Reunion/586/04 (R/H3NA-) H3NA- strains
without any NA segment on the A/Moscow/10/99 genetic
background was attempted (Table 1). Two passages on MDCK
cells were then performed.
L/H3NA- and R/H3NA- viruses were not able to grow on
MDCK cells as no cytopathic effect (CPE) and no infectivity
(TCID50/50 ml) was detectable (Table 1). This implies that the low
affinity HA alone is not sufficient to render the A/Moscow/10/99
virus independent of the NA gene. The two viruses R/E119D/
I222L and L/E119D/I222L induced a CPE on MDCK cells.
Their TCID50/50 ml were respectively 10
4.7 and 10
5.4.
RNA Amplification
To verify that the E119D/I222L NA segments were incorpo-
rated in the virions, we performed plaques assays after the second
passage on MDCK cells. Since the plaque morphologies were
homogenous (1 mm), we extracted RNA from the viral stocks and
specifically amplified the NA gene. After three passages in MDCK
cells, the E119D/I222L mutation in the NA gene segment was
shown to be preserved and no changes in sequence were detected.
The HA genes of the R/E119D/I222L and L/E119D/I222L
viruses were also analysed and no modifications were observed.
Phenotypic Characteristics of NA
The P2 viruses were used to infect MDCK cells at a multiplicity
of infection (m.o.i) of 0.001 and viruses were harvested 96 h post-
infection. The viruses were concentrated through a saccharose
cushion and then purified on a saccharose gradient. The purified
viruses were standardized relative to the quantity of nucleoprotein
(NP). The NA activities of the R/E119D/I222L and L/E119D/
I222L viruses were measured by a fluorimetric assay using a
synthetic MUNANA substrate. Under these conditions, no NA
activity was detected either for the L/E119D/I222L or R/
E119D/I222L virus whereas the NA activity of the A/Moscow/
10/99 virus was of 603 nmol of MUNANA/h/ml (results from
four independent assays). These results indicate that the
combination of the E119D/I222L mutations abolishes the NA
activity of the recombinant viruses. We also observed that the
mutant NA was not detectable, using two monoclonal antibodies,
in the L/E119D/I222L and R/E119D/I222L virions, or in 293T
cells transfected with a plasmid containing the mutant NA (see
Material and Methods S1, Results S1, Table S1 and Figures S1,
S2 and S3).
Kinetics in MDCK Cells
To evaluate the replicative capacities of the L/E119D/I222L
and R/E119D/I222L viruses in comparison to the A/Moscow/
10/99 virus, we monitored growth kinetics in MDCK cells by
determining infectivity (TCID50/50 ml) over a 96 h time period
(Figure 2).
Growth of the two R/E119D/I222L and L/E119D/I222L
viruses was similar but the kinetics were slower than for the A/
Moscow/10/99 virus. A plateau was reached at 60 h post-
infection for both recombinant viruses at an infectivity titre about
2.5-log lower than for the A/Moscow/10/99 virus. At 96 h post-
infection, some cellular monolayer remained implying that the
recombinant viruses were not able to infect all the cells.
Discussion
During 2003–2004, Ferraris et al. isolated four viruses lacking
both a NA gene and protein [14]. Of these, two isolates A/Lyon-
CHU/26430/03 and A/Reunion/586/04 (H3NA- viruses) were
further analyzed and the HA gene was shown to be one of the
principal determinants for the virus to be independent of the NA
[15]. In this study, we showed that the HAs of these H3NA-
viruses have reduced affinity for their receptors and hypothesized
that this low affinity might compensate for deficiency in NA,
activity and protein, of recombinant A/Moscow/10/99 (back-
ground) viruses.
Table 1. Recombinant viruses produced by reverse genetics and their growth characteristics after two passages in MDCK cells.
Virus name Origin of the genes
Growth characteristics after the
2
nd passage in MDCK
Core
a HA NA CPE
b Log10 TCID50/50 ml
c
L/E119D/I222L A/Moscow/10/99 A/Lyon-CHU/26430/03 E119D/I222L A/Moscow/10/99 +++ 5.4 +/–0,1
R/E119D/I222L A/Moscow/10/99 A/Reunion/586/04 E119D/I222L A/Moscow/10/99 +++ 4.7 +/–0
L/H3NA- A/Moscow/10/99 A/Lyon-CHU/26430/03 No NA - ,1
R/H3NA- A/Moscow/10/99 A/Reunion/586/04 No NA - ,1
aCore defined by the PB1, PB2, PA, NP, NS and M genes.
bCPE for cytopathic effect. – no visible CPE. +++ visible CPE.
cTCID50/50 ml : dose infecting 50% the cell culture determined in MDCK cells.
doi:10.1371/journal.pone.0033880.t001
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and A/Reunion/586/04, possessed similar low affinities for
69SLN receptors and no detectable affinity for 39SL receptors.
However, no mutations were observed in conserved residues of the
RBS or elsewhere in the sequences of the HAs of the two H3NA-
viruses, relative to contemporary viruses, which might account for
altered binding. An alternative mechanism for the low HA affinity
of the two H3NA- viruses could be the absence of desialylation of
carbohydrate residues in the vicinity of the RBS, due to the total
absence of NA activity, leading to a reduced accessibility for the
receptor [20,21]. Whatever the basis, the low HA affinity of these
two natural isolates explains how these viruses are able to replicate
in the absence of any detectable NA activity and protein.
The low receptor binding affinity of these HAs also allowed the
rescue of an A/Moscow/10/99 recombinant virus containing a
defective NA. The deficiency of the NA is due to a double
mutation in framework sites (E119D/I222L), abolishing the
replicative capacity of the recombinant A/Moscow/10/99 virus
in MDCK cells in the absence of complementation by bacterial
NA activity [14]. The L/E119D/I222L and R/E119D/I222L
viruses had no detectable NA activity. The presence of the
mutated E119D/I222L NA, both in transfected cells and in virion,
was assessed using two different monoclonal antibodies and
different techniques. Even though the results are not totally
conclusive in the absence of a positive control for the detection of
the mutant protein by the antibodies, our observations indicate
that the mutation E119D/I222L might be deleterious for the
expression of the NA, and consequently for NA activity.
Moreover, using the HAs of the H3NA- viruses, we have been
able to rescue, viruses containing a defective interfering NA RNA
instead of the full NA gene (data not shown). Taken together, we
have shown that the low affinity of the H3NA- virus HAs can
compensate for the absence of both NA activity and of the NA
protein. However, the L/H3NA- and R/H3NA- control viruses,
containing the HA of the H3NA- viruses and six A/Moscow/10/
99 virus genes, but lacking the NA gene, could not be rescued, in
contrast to a complement of seven genes of the H3NA- viruses
(Table 2). This implies that the low affinity of the HA alone is not
sufficient to rescue the A/Moscow/10/99 genetic background in
the absence of the NA gene and that other internal genes or
proteins might play a role in the independence of the H3NA-
viruses from the NA gene. Specific characteristics of the PB1 gene
and/or protein might be implicated as the PB1 gene was found to
be a determining factor, in addition to HA, for the ‘‘7 segment
phenotype’’ [15].
The NA plays a role in desialylating cellular and most
importantly viral glycoproteins, enabling the progeny virions to
avoid self-aggregation and to be released from host cells. The low
HA affinity of the two H3NA- viruses allows the virus to be
independent from NA activity. This implies that, even if the HA is
not desialylated, the HA on its own dissociates from its receptor
and the progeny virions do not aggregate.
Furthermore, the two natural H3NA- isolates A/Lyon-CHU/
26430/03 and A/Reunion/586/04 did not exhibit reduction in
replicative capacities in MDCK cells compared to A/Moscow/
10/99 [14], in contrast to the L/E119D/I222L and R/E119D/
I222L viruses. Whether the low replication of the latter viruses is
due to reduced association of HA with sialylated receptors or a
consequence of defective expression of the mutant NA, rather than
its absence, is not evident from the available data. These results are
however consistent with a role for internal genes/proteins, such as
PB1, in complementing low HA affinity and absence of NA
activity. Together, these observations emphasize the complexity in
the interrelationships among different factors in optimizing the
complementary activities of the HA and NA in virus replication.
Materials and Methods
Cells
Madin-Darby Canine Kidney (MDCK) cells used for produc-
tion of viruses were purchased from Cambrex Bioscience (ATCC,
CCL34) and were maintained in serum-free medium for MDCK
cells (UltraMDCK, Lonza) supplemented with 1% L-Glutamine
(L-Gln, 200 mM, Lonza) and 2% Penicillin-Streptomycin (PS,
10000 U Penicillin/ml, 10000 U Streptomycin/ml, Lonza).
MDCK cells used for reverse genetics were maintained in
Minimum Essential Medium, Eagle’s with Earle’s Balanced Salt
Solution without L-glutamine (EMEM, Lonza) supplemented with
1% L-Gln, 2% PS, 10% Foetal Bovine Serum (FBS, Lonza) and
1% Non Essential Amino Acids (NEAA 100X, Lonza).
293T cells, purchased from the ATCC (CRL-11-268), were
maintained in Dulbecco’s modified Eagle’s medium with 4.5 g/
l glucose without L-glutamine (DMEM) supplemented with 1% L-
Gln, 2% PS and 10% FBS.
Viruses
The isolates A/Lyon-CHU/26430/03, A/Reunion/586/04
and the A/Moscow/10/99 viruses were obtained from the
National Reference Center (Lyon).
The A/Moscow/10/99 virus used in this study was produced
by reverse genetics [16]. After verification of the homogeneity of
the population, the fifth passage in MDCK cells was purified and
used to perform the experiments.
We used an eight-plasmid system to generate recombinant
viruses on the A/Moscow/10/99 background with combinations
of the hemagglutinin genes from A/Lyon-CHU/26430/03 or A/
Reunion/586/04 and the double mutant E119D/I222L neur-
aminidase gene from the A/Moscow/10/99 strain, as previously
Figure 2. Kinetics of virus growth experiments in MDCK cells.
P2 MDCK viruses were used to infect MDCK cells at a m.o.i of 0.001.
Supernatants were harvested at the indicated times. The TCID50/50 ml
values correspond to the mean +/– standard deviation calculated from
two independent assays.
doi:10.1371/journal.pone.0033880.g002
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plasmid were used to transfect 293T cells in co-culture with
MDCK cells, using Superfect Reagent. 72 h post-transfection, the
supernatants were harvested and preserved at 280uC.
Affinity of the Hemagglutinin for Sialic Acid Receptors
32 hemagglutination (HA) units of each virus in 50 ml of PBS
were coated on 96-well plates (NUNC MAXISORP) over-night at
room temperature in a humid atmosphere. Three five-minute
washings with PBS, 0.05% Tween (Sigma) (130 ml/well) were then
performed with gentle agitation at room temperature. Saturation
by adding 100ml/well of Blocking Reagent (Roche) was for one
hour at 37uC followed by three washings. In order to inhibit the
NA activity, 96-well plates were incubated 30 min at 4uC and the
remainder of the assay was done on ice using cold buffers. 50 ml/
well of the biotinylated sialylglycopolymers Neu5Aca2-3Galß1-
4Glc-PAA-Biotin (39SL) and Neu5Aca2-6Galß1-4GlcNAc-PAA-
Biotin (69SLN) serially diluted two-fold in PBS, 0.05% Tween,
0,1% bovine serum albumin (BSA) and 10 mM zanamivir were
added for 2 h at 4uC. Three five-minute washings with PBS 0.05%
Tween, 10 mM of zanamivir (130 ml/well) were then performed
with gentle agitation at room temperature. Anti-biotin antibody
coupled to Horseradish Peroxidase (Euromedex) diluted in PBS,
0.05% Tween, 0,1% BSA, 10 mM zanamivir (50 ml/well) was then
added and incubated 2 h at 4uC followed by three five-minute
washings with PBS, 0.05% Tween, 10 mM of zanamivir (130 ml/
well) with gentle agitation at room temperature. The peroxidase
reaction with TMB substrate (0.2 g/l of Tetramethylbenzidine,
KPL) for 5 min with shaking in the dark was stopped with 50 ml/
well of phosphoric acid at 0,8 mol/l. Optical density at 450 nm
was determined with a microplate reader (UMV 340 Asys,
BioServ).
Blank-corrected data were plotted and fitted with two
established binding models by non-linear least-squares regressions
with R software. The first model was the Michaelis-Menten
equation for reversible monovalent binding (MM model [22]),
based on one site per receptor and negligible ligand depletion. The
equation was the following:
y~
r0|x
Kdzx
with r0, the number of sites and Kd, the dissociation constant, both
parameters to be fitted.
The second model was an adaptation of the Michaelis-Menten
model (MM2 model) based on two sites of different affinities per
receptor. The resulting equation was the sum of two different MM
models, one for each site subpopulation:
y~
r01|x
Kd1zx
z
r02|x
Kd2zx
withr01~r02~
r0
2
:
Assuming that receptors are bivalent, the total number of sites of
both types is the same, leaving three parameters to be fitted : r0,
Kd1 and Kd2.
We used the Bayesian Information Criterion (BIC), a tool able
to discriminate among a class of parametric models with different
numbers of parameters [23]. The BIC is very sensitive to
overfitting as it introduces a penalty term for the number of
parameters in the model.
BIC~n|ln(s)zk|ln(n)
with n, the number of observations, k, the number of parameters
and s the error variance. When comparing different models for the
same data, the smaller the criterion value, the better the model. If
our test allows us to detect the secondary site, the MM2 model
should turn out to be the better model.
Passage on MDCK Cells
Viruses produced by reverse genetics were passaged two times
in MDCK cells. For the first passage, confluent MDCK cells were
inoculated with 10-fold dilutions of viruses in EMEM, 2% PS, 1%
L-Gln, 1 mg/ml of trypsin (Roche) (working medium) for one hour
at 34uC. Fresh working medium was then added to the cultures
and supernatants were harvested after varying times, depending
on the appearance of cytopathic effect to ensure a good
amplification of virus. For the second passage, 0.01 m.o.i were
used to infect confluent MDCK monolayers. The inoculum was
withdrawn and fresh working medium added to the culture. The
viruses were harvested 72 h post-infection to allow comparison of
the replicative capacities.
Purification of Viruses
Second passage (P2) viruses were used to infect MDCK cells at a
m.o.i of 0.001. Supernatants were harvested depending on the
cytopathic effect and centrifuged at 1800 g for 10 min to eliminate
cellular debris. Viruses were then concentrated through a
25% (w/w) saccharose cushion by ultracentrifugation for 2 h at
126000 g. Pellets were resuspended in HBS-N buffer (0.01M
HEPES, 0.15M NaCl, pH=7.4) and centrifuged through a linear
Table 2. Experiments done on H3NA- viruses.
Plasmid tranfected Virus Rescue Study
Virus name Core HA NA NA
gene protein
E119D/I222L A/Moscow/10/99 A/Moscow/10/99 E119D/I222L N.D. N.D. no [16]
L/E119D/I222L A/Moscow/10/99 A/Lyon-CHU/26430/03 E119D/I222L E119D/I222L no yes this study
R/E119D/I222L A/Moscow/10/99 A/Reunion/586/04 E119D/I222L E119D/I222L no yes this study
L/H3NA- A/Moscow/10/99 A/Lyon-CHU/26430/03 No NA no no no this study
R/H3NA- A/Moscow/10/99 A/Reunion/586/04 No NA no no no this study
H3NA- A/Reunion/586/04 A/Reunion/586/04 No NA no no yes [15]
doi:10.1371/journal.pone.0033880.t002
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without brake. Bands of purified viruses were harvested and
saccharose was removed by diluting the viruses ten times in PBS
and by centrifugating at 126000 g for 2 h. The final pellets were
resuspended in HBS-N buffer, aliquoted and preserved at 280uC.
The total amount of viral protein was determined using a Micro
BCA Protein Assay Kit (Thermo Scientific, Pierce), according to
the manufacturer’s instructions.
Infectivity Titration
Infectious titers (TCID50/50 ml), were determined on confluent
MDCK cells as previously described [16]. Briefly, tenfold serial
dilutions of viruses were inoculated in quadruplicate onto MDCK
cells. Endpoints were determined by HA tests performed with
0.8% guinea pig red blood cells for one hour at room temperature.
TCID50/50 ml were calculated by the Reed and Muench test [24].
Plaque Assays
Confluent MDCK cell monolayers were incubated for one hour
withtenfoldserialdilutionsofP2MDCKvirusesinworkingmedium.
The supernatants were withdrawn and the cells were overlaid with
freshly prepared EMEM (2x concentrate, Lonza) containing 0.55%
agar (Agar Noble, Difco) and 1 mg/ml of trypsin. The plaques were
visualized 72 h post-infection after staining with a solution containing
0,7% agar and 0.02% neutral red (Sigma) in PBS.
HA and NA Sequencing
RNA extracted from the viral stocks was reverse transcribed and
the NA and HA genes were specifically amplified and sequenced
(GATC Biotech). Sequences were analysed by SeqMan software.
NA Activity Assays
Fluorimetric NA activity assays were done as described by
Ferraris et al. [14]. Total NA activities were calculated as the
quantity of MUNANA substrate degraded in one hour per ml of
virus suspensions (nmol/h/ml).
Kinetics of Growth in MDCK Cells
Confluent MDCK cells monolayers were infected for one hour
with the appropriate dilutions of viruses, at a m.o.i of 0.001 in a
minimum volume of working medium. The supernatants were
withdrawn and the cells were washed two times with PBS and then
overlaid with working medium. At the indicated times, superna-
tants were harvested and frozen at -80uC. Infectious titers of each
sample were determined on confluent MDCK cells as described in
the preceding section.
Supporting Information
Material and Methods S1 Quantification of the expres-
sion of wild type and E119D/I222L NAs in transfected
293T by flow cytometry. Quantification of wild type and
E119D/I222L NAs in virions using an ELISA-based assay.
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Results S1 Expression of wild type and E119D/I222L
NAs in transfected 293T and at their cell membrane.
Quantity of NA in L/E119D/I222L and R/E119D/I222L virions.
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Figure S1 Flow cytometry of transfected non-permea-
bilized stained 293T cells. The gate P3 represents the number
of fluorescent cells. A. Staining with the M9G3D5 mouse
monoclonal antibody and FITC-A labelled goat anti-mouse IgG
antibody. 293T cells transfected with A1, NA A/Moscow/10/99
wild type, A2, NA A/Moscow/10/99 E119D/I222L and A3,
pHW2000. B. Staining with the M6G5D6 mouse monoclonal
antibody and FITC-A labelled goat anti-mouse IgG antibody.
293T cells transfected with B1, NA A/Moscow/10/99 wild type,
B2, NA A/Moscow/10/99 E119D/I222L and B3, pHW2000. C.
Staining with the NR-4540 mouse monoclonal antibody and
FITC-A labelled goat anti-mouse IgG antibody. 293T cells
transfected with C1, PR8 and C2, pHW2000.
(TIF)
Figure S2 Flow cytometry of transfected permeabilized
stained 293T cells. The gate P3 represents the number of
fluorescent cells. A. Staining with the M9G3D5 mouse monoclo-
nal antibody and FITC-A labelled goat anti-mouse IgG antibody.
293T cells transfected with A1, NA A/Moscow/10/99 wild type,
A2, NA A/Moscow/10/99 E119D/I222L and A3, pHW2000. B.
Staining with the M6G5D6 mouse monoclonal antibody and
FITC-A labelled goat anti-mouse IgG antibody. 293T cells
transfected with B1, NA A/Moscow/10/99 wild type, B2, NA
A/Moscow/10/99 E119D/I222L and B3, pHW2000. C. Staining
with the NR-4540 mouse monoclonal antibody and FITC-A
labelled goat anti-mouse IgG antibody. 293T cells transfected with
C1, PR8 and C2, pHW2000. D. 293T cells transfected with D2,
EGFP-N1 and D3, pHW2000
(TIF)
Figure S3 NA protein detection in A/Moscow/10/99, L/
E119D/I222L and R/E119D/I222L viruses. The NA
protein was detected by an ELISA-based assay using a monoclonal
antibody directed against the NA of A/Moscow/10/99. Blank-
corrected data result from three independent assays and were
plotted against A/Moscow/10/99 virus total protein.
(TIFF)
Table S1 Expression of different NAs in 293T cells
determined by flow cytometry after permeabilization,
or not, of the cell membrane.
(DOCX)
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